Introduction: The coronavirus 2019 (COVID-19) pandemic has become a major world health
problem. All US states have advised their cystic fibrosis (CF) populations to socially isolate …

Background Cystic fibrosis (CF) programs and people with CF (PwCF) employed various
monitoring methods for virtual care during the COVID-19 pandemic. This paper …

Introduction: The University of Virginia's (UVA's) adult cystic fibrosis (CF) program
implemented a rapid and successful transition to telemedicine care mid-March of 2020 in …

Introduction The Cystic Fibrosis (CF) Foundation chronic care guidelines recommend
monitoring spirometry during quarterly multidisciplinary visits to identify early lung function …

Introduction Lower socioeconomic status is associated with significantly poorer outcomes in
weight, lung function, and pulmonary exacerbation rates in people with cystic fibrosis …

Background Treatment of cystic fibrosis (CF) has been revolutionized by the use of cystic
fibrosis transmembrane conductance regulator (CFTR) protein modulators such as …

Background During the COVID-19 pandemic, the University of Virginia adult cystic fibrosis
(CF) center transitioned from in-person clinical encounters to a model that included …

Introduction: Persons with cystic fibrosis (CF) have higher rates of depression and anxiety
compared to the general population. The Cystic Fibrosis Foundation guidelines recommend …

Introduction Cystic fibrosis (CF) is a systemic autosomal recessive condition characterised
by progressive lung disease. CF pulmonary exacerbations (PEx) are episodes of worsening …

Background Iron deficiency is highly prevalent in people with cystic fibrosis (PwCF). While
elexacaftor/tezacaftor/ivacaftor (ETI) has shown remarkable improvements in respiratory …